Abound Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.71K | Hold |
31
| – | – | ﹤0.01% | 703 |
|
2025
Q1 | $2.12K | Sell |
31
-20
| -39% | -$1.37K | ﹤0.01% | 692 |
|
2024
Q4 | $3.97K | Sell |
51
-2
| -4% | -$156 | ﹤0.01% | 574 |
|
2024
Q3 | $3.55K | Sell |
53
-7
| -12% | -$469 | ﹤0.01% | 617 |
|
2024
Q2 | $6.78K | Sell |
60
-1
| -2% | -$113 | ﹤0.01% | 440 |
|
2024
Q1 | $8.44K | Sell |
61
-6
| -9% | -$830 | ﹤0.01% | 406 |
|
2023
Q4 | $8.3K | Buy |
67
+25
| +60% | +$3.1K | ﹤0.01% | 404 |
|
2023
Q3 | $3.92K | Sell |
42
-2
| -5% | -$187 | ﹤0.01% | 515 |
|
2023
Q2 | $5.66K | Buy |
44
+2
| +5% | +$257 | ﹤0.01% | 456 |
|
2023
Q1 | $4.88K | Buy |
42
+10
| +31% | +$1.16K | ﹤0.01% | 412 |
|
2022
Q4 | $3.62K | Sell |
32
-64
| -67% | -$7.25K | ﹤0.01% | 418 |
|
2022
Q3 | $7.73K | Buy |
+96
| New | +$7.73K | ﹤0.01% | 307 |
|